{"nct_id":"NCT01350401","title":"Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma","status":"TERMINATED","status_verified_date":"2019-01","start_date":"2011-06-01","start_date_type":"ACTUAL","primary_completion_date":"2016-02-17","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ADAP"]}